Treatment of human immunodeficiencies.
D000243:Adenosine Deaminase / Q000172:deficiency; D000361:Agammaglobulinemia / Q000235:genetics / Q000276:immunology; D000818:Animals; D016026:Bone Marrow Transplantation; D002178:Candidiasis, Chronic Mucocutaneous / Q000276:immunology; D002454:Cell Differentiation; D004062:DiGeorge Syndrome / Q000276:immunology; D004195:Disease Models, Animal; D004848:Epithelium / Q000637:transplantation; D005260:Female; D005333:Fetus; D006087:Graft vs Host Reaction; D006098:Granulocytes / Q000473:pathology; D006105:Granulomatous Disease, Chronic / Q000276:immunology; D006648:Histocompatibility; D006734:Horse Diseases / Q000276:immunology; D006736:Horses; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage; D007153:Immunologic Deficiency Syndromes / Q000151:congenital / Q000628:therapy*; D007231:Infant, Newborn; D016031:Liver Transplantation; D008221:Lymphoid Tissue / Q000196:embryology; D008297:Male; D011683:Purine-Nucleoside Phosphorylase / Q000172:deficiency; D013950:Thymus Gland / Q000473:pathology / Q000637:transplantation; D014923:Wiskott-Aldrich Syndrome / Q000276:immunology
D007136:Immunoglobulins; D011683:Purine-Nucleoside Phosphorylase; D000243:Adenosine Deaminase